Critical role of autophagy in the processing of adenovirus capsid-incorporated cancer-specific antigens

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Klein, Sarah R ^a,b,d   Jiang, Hong ^a   Hossain, Mohammad B ^a   Fan, Xuejun ^a   Gumin, Joy ^a   Dong, Andrew ^a   Alonso, Marta M ^c   Gomez Manzano, Candelaria ^a,b   Fueyo, Juan ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR VIII ANTIBODY; EPITOPE; PROTEIN P62; RECEPTOR PROTEIN; RINDOPEPIMUT; STRESS ACTIVATED PROTEIN KINASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS FIBER PROTEIN; ONCOLYTIC VIRUS;

ADENOVIRIDAE; ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOLYSOSOME; AUTOPHAGY; CANCER CELL; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX II; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA INTERFERENCE; SPLEEN CELL; VIRUS CAPSID; WILD TYPE; ADENOVIRUS INFECTION; ANIMAL; C57BL MOUSE; GENE VECTOR; HELA CELL LINE; IMMUNOLOGY; NEOPLASMS; ONCOLYTIC VIROTHERAPY; PROCEDURES; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; AUTOPHAGY; CAPSID; CAPSID PROTEINS; CELL LINE, TUMOR; EPITOPES; GENETIC VECTORS; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; VIRUS REPLICATION;

EID: 84966280656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153814     Document Type: Article

References (40)

1. Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, et al. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. Journal of the National Cancer Institute. 2003; 95(9):652-60. Epub 2003/05/08. PMID: 12734316.
2. Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clinical cancer research: an official journal of the American Association for Cancer Research. 2001; 7(1):120-6. Epub 2001/02/24. PMID: 11205899.
3. Bessis N, GarciaCozar FJ, Boissier MC. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene therapy. 2004; 11 Suppl 1:S10-7. Epub 2004/09/30. doi: 10.1038/sj.gt.3302364 PMID: 15454952.
4. Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nature biotechnology. 2012; 30(7):658-70. Epub 2012/07/12. doi: 10.1038/nbt.2287 PMID: 22781695; PubMed Central PMCID: PMC3888062.
5. Ito H, Aoki H, Kuhnel F, Kondo Y, Kubicka S, Wirth T, et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. Journal of the National Cancer Institute. 2006; 98(9):625-36. Epub 2006/05/04. doi: 10.1093/jnci/djj161 PMID: 16670388.
6. Piya S, White EJ, Klein SR, Jiang H, McDonnell TJ, Gomez-Manzano C, et al. The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PloS one. 2011; 6(12): e29467. Epub 2012/01/14. doi: 10.1371/journal.pone.0029467 PMID: 22242123; PubMed Central PMCID: PMC3248451.
7. Jiang H, White EJ, Rios-Vicil CI, Xu J, Gomez-Manzano C, Fueyo J. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. Journal of virology. 2011; 85 (10):4720-9. Epub 2011/03/04. doi: 10.1128/JVI.02032-10 PMID: 21367888; PubMed Central PMCID: PMC3126198.
8. Birmingham CL, Canadien V, Kaniuk NA, Steinberg BE, Higgins DE, Brumell JH. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature. 2008; 451(7176):350-4. Epub 2008/01/19. doi: 10.1038/nature06479 PMID: 18202661.
9. Munz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, Kurilla MG, et al. Human CD4(+)Tlymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. The Journal of experimental medicine. 2000; 191(10):1649-60. Epub 2000/05/17. PMID: 10811859; PubMed Central PMCID: PMC2193162.
10. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science. 2005; 307(5709):593-6. Epub 2004/12/14. doi: 10.1126/science.1104904 PMID: 15591165.
11. Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, et al. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. European journal of immunology. 2007; 37 (3):788-97. Epub 2007/02/17. doi: 10.1002/eji.200636620 PMID: 17304627.
12. Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2is phosphorylatedand inhibited by Akt and suppresses mTOR signalling. Nature cell biology. 2002; 4(9):648-57. Epub 2002/08/13. doi: 10.1038/ncb839 PMID: 12172553.
13. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003; 115(5):577-90. Epub 2003/12/04. PMID: 14651849.
14. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology. 2011; 13(2):132-41. Epub 2011/01/25. doi: 10.1038/ncb2152 PMID: 21258367.
15. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Molecular cell. 2008; 30(6):678-88. Epub 2008/06/24. doi: 10.1016/j.molcel.2008.06.001 PMID: 18570871; PubMed Central PMCID: PMC2478643.
16. Klein SR, Piya S, Lu Z, Xia Y, Alonso MM, White EJ, et al. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015. doi: 10.1038/onc.2014.452 PMID: 25619840.
17. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annual review of immunology. 2002; 20:55-72. Epub 2002/02/28. doi: 10.1146/annurev.immunol.20.091301.131133 PMID: 11861597.
18. Basner-Tschakarjan E, Gaffal E, O'Keeffe M, Tormo D, Limmer A, Wagner H, et al. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. The journal of gene medicine. 2006; 8(11): 1300-6. Epub 2006/09/05. doi: 10.1002/jgm.964 PMID: 16952196.
19. Minamitani T, Iwakiri D, Takada K. Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway. Journal of virology. 2011; 85(8):4035-40. Epub 2011/01/21. doi: 10.1128/JVI.02160-10 PMID: 21248047; PubMed Central PMCID: PMC3126113.
20. Ip YT, Davis RJ. Signal transduction bythec-Jun N-terminal kinase (JNK)-from inflammation to development. Current opinion in cell biology. 1998; 10(2):205-19. Epub 1998/04/30. PMID: 9561845.
21. Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, et al. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1990; 87(11):4207-11. Epub 1990/06/01. PMID: 1693434; PubMed Central PMCID: PMC54077.
22. Krause A, Joh JH, Hackett NR, Roelvink PW, Bruder JT, Wickham TJ, et al. Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity. Journal of virology. 2006; 80(11):5523-30. Epub 2006/05/16. doi: 10.1128/JVI.02667-05 PMID: 16699033; PubMed Central PMCID: PMC1472137.
23. Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, et al. Ovarian cancer targeted adenoviral-mediatedmda-7/IL-24 gene therapy. Gynecologic oncology. 2006; 100(3):521-32. Epub 2005/10/18. doi: 10.1016/j.ygyno.2005.08.042 PMID: 16225913.
24. Piao Y, Jiang H, Alemany R, Krasnykh V, Marini FC, Xu J, et al. Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer gene therapy. 2009; 16(3):256-65. Epub 2008/10/18. doi: 10.1038/cgt.2008.75 PMID: 18927600.
25. Jiang H, Clise-Dwyer K, Ruisaard KE, Fan X, Tian W, Gumin J, et al. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PloSone. 2014; 9(5):e97407. Epub 2014/05/16. doi: 10.1371/journal.pone.0097407 PMID: 24827739; PubMed Central PMCID: PMC4020829.
26. Hecht TT, Longo DL, Matis LA. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restrictedTcell lines and clones. J Immunol. 1983; 131(3):1049-55. Epub 1983/09/01. PMID: 6193170.
27. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(24):13681-6. Epub 2001/11/22. doi: 10.1073/pnas.251194298 PMID: 11717429; PubMed Central PMCID: PMC61101.
28. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell structure and function. 1998; 23(1):33-42. Epub 1998/06/25. PMID: 9639028.
29. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. RAFT1: a mammalian protein that binds to FKBP12ina rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 1994; 78 (1):35-43. Epub 1994/07/15. PMID: 7518356.
30. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Molecular cell. 2009; 34(3):259-69. Epub 2009/05/20. doi: 10.1016/j.molcel.2009.04.026 PMID: 19450525.
31. Matthews QL Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach. Molecular pharmaceutics. 2011; 8(1):3-11. Epub 2010/11/05. doi: 10.1021/mp100214b PMID: 21047139; PubMed Central PMCID: PMC3034826.
32. Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene. 2000; 19(1):2-12. Epub 2000/01/25. doi: 10.1038/sj.onc.1203251 PMID: 10644974.
33. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994; 265(5168):106-9. Epub 1994/07/01. PMID: 8016643.
34. SumpterR Jr, Levine B. Selective autophagy and viruses. Autophagy. 2011; 7(3):260-5. Epub 2010/12/15. PMID: 21150267; PubMed Central PMCID: PMC3060412.
35. Bevan MJ Helping the CD8(+) T-cell response. Nature reviews Immunology. 2004; 4(8):595-602. doi: 10.1038/nri1413 PMID: 15286726.
36. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Muller M, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(22):7922-7. Epub 2005/05/17. doi: 10.1073/pnas.0501190102 PMID: 15894616; PubMed Central PMCID: PMC1142372.
37. Andersson M, Paabo S, Nilsson T, Peterson PA. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 1985; 43(1):215-22. Epub 1985/11/01. PMID: 2934137.
38. Worgall S, Busch A, Rivara M, Bonnyay D, Leopold PL, Merritt R, et al. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. Journal of virology. 2004; 78(5):2572-80. Epub 2004/02/14. PMID: 14963160; PubMed Central PMCID: PMC369215.
39. Alonso MM, Jiang H, Yokoyama T, Xu J, Bekele NB, Lang FF, et al. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Molecular therapy: the journal of the American Society of Gene Therapy. 2008; 16(3):487-93. Epub 2008/02/07. doi: 10.1038/sj.mt.6300400 PMID: 18253154.
40. Alonso MM, Gomez-Manzano C, Jiang H, Bekele NB, Piao Y, Yung WK, et al. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. Cancer gene therapy. 2007; 14(8):756-61. Epub 2007/06/09. doi: 10.1038/sj.cgt.7701067 PMID: 17557108.